Lovastatin enhances the antitumoral and apoptotic activity of doxorubicin in murine tumor models
Despite its effectiveness as an antineoplastic drug, doxorubicin (DOX) is usually associated with cardiotoxicity. Lovastatin (LOV), a hypolipidemic agent used in the clinic, has been demonstrated to have antitumoral and antimetastatic effects in murine models. Since the two agents arrest tumor cells...
Guardado en:
| Autores principales: | Rozados, Viviana R., Hinrichsen, Lucila Isabel, Binda, María Mercedes, Gervasoni, Silvia I., Matar, Pablo, Bonfil, Daniel R., Scharovsky, O. Graciela |
|---|---|
| Formato: | artículo publishedVersion article |
| Lenguaje: | Inglés |
| Publicado: |
Spandidos (Grecia)
2012
|
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/2133/2014 http://hdl.handle.net/2133/2014 |
| Aporte de: |
Ejemplares similares
-
Therapeutic efficacy of metronomic chemotherapy with cyclophosphamide and doxorubicin on murine mammary adenocarcinomas
por: Mainetti, Leandro Ernesto, et al.
Publicado: (2018) -
Hsp25 and Hsp70 in rodent tumors treated with doxorubicin and lovastatin
por: Ciocca, Daniel R., et al.
Publicado: (2012) -
Genistein suppresses doxorubicin associated genotoxicity in human lymphocytes
por: Beg, Tanveer, et al.
Publicado: (2011) -
Co-treatment of tumor cells with hyaluronan plus doxorubicin affects endothelial cell behavior independently of VEGF expression
por: Vitale, Daiana Luján, et al.
Publicado: (2023) -
Binding and Encapsulation of Doxorubicin on Smart Pectin Hydrogels for Oral Delivery
por: Bosio, Valeria Elizabeth, et al.
Publicado: (2012)